Photodynamic therapy: Current status and future directions

Medical Principles and Practice

Volumn 24, Issue , 2015, Pages 14-28

  Benov, Ludmil ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Hydroxyl radical; Photodynamic therapy; Photosensitizer; Porphyrin; Singlet oxygen; Superoxide

Indexed keywords

HYDROXYL RADICAL; LIPID; NUCLEIC ACID; PHOTOSENSITIZING AGENT; PROTEIN; CELL SURFACE RECEPTOR; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; TUMOR PROTEIN;

ANEMIA; CELL DEATH; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONSTIPATION; CYTOSKELETON; DNA DAMAGE; DNA MODIFICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DRUG UPTAKE; EDEMA; ELECTRICITY; ERYTHEMA; HUMAN; LIPID PEROXIDATION; LIPOPHILICITY; LYSOSOME; MEMBRANE; MITOCHONDRION; PAIN; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOOXIDATION; PHOTOPHOBIA; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PLEURA EFFUSION; PROTEIN TARGETING; RESPIRATORY FAILURE; TARGET CELL; BLOOD VESSEL; CHEMISTRY; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; METABOLISM; NEOPLASMS; PHOTOCHEMOTHERAPY; PROCEDURES;

BLOOD VESSELS; CLINICAL TRIALS AS TOPIC; HUMANS; NANOPARTICLES; NEOPLASM PROTEINS; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; RECEPTORS, CELL SURFACE;

EID: 84928612047     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000362416     Document Type: Conference Paper

References (144)

1. Dougherty TJ, Gomer CJ, Henderson BW, et al: Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905.
2. Waksman R, McEwan PE, Moore TI, et al: PhotoPoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression. J Am Coll Cardiol 2008; 52: 1024-1032.
3. Woodburn KW, Fan Q, Kessel D, et al: Phototherapy of cancer and atheromatous plaque with texaphyrins. J Clin Laser Med Surg 1996; 14: 343-348.
4. Bozzini G, Colin P, Betrouni N, et al: Photodynamic therapy in urology: what can we do now and where are we heading? Photodiagnosis Photodyn Ther 2012; 9: 261-273.
5. Cotter TG: Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009; 9: 501-507.
6. Silva JN, Filipe P, Morliere P, et al: Photodynamic therapy: dermatology and ophthalmology as main fields of current applications in clinic. Biomed Mater Eng 2008; 18: 319-327.
7. Michels S, Schmidt-Erfurth U: Photodynamic therapy with verteporfin: a new treatment in ophthalmology. Semin Ophthalmol 2001; 16: 201-206.
8. Meisel P, Kocher T: Photodynamic therapy for periodontal diseases: state of the art. J Photochem Photobiol B 2005; 79: 159-170.
9. Konopka K, Goslinski T: Photodynamic therapy in dentistry. J Dental Res 2007; 86: 694-707.
10. Babilas P, Schreml S, Landthaler M, et al: Photodynamic therapy in dermatology: state-ofthe-art. Photodermatol Photoimmunol Photomed 2010; 26: 118-132.
11. Lee Y, Baron ED: Photodynamic therapy: current evidence and applications in dermatology. Semin Cutan Med Surg 2011; 30: 199-209.
12. Szeimies RM, Lischner S, Philipp-Dormston W, et al: Photodynamic therapy for skin rejuvenation: treatment options-results of a consensus conference of an expert group for aesthetic photodynamic therapy. J Dtsch Dermatol Ges 2013; 11: 632-636.
13. Taub AF: Cosmetic clinical indications for photodynamic therapy. J Cosmet Dermatol 2012; 25: 218-224.
14. Costa L, Faustino MAF, Neves MGPMS, et al: Photodynamic inactivation of mammalian viruses and bacteriophages. Viruses 2012; 4: 1034-1074.
15. Wainwright M: Local treatment of viral disease using photodynamic therapy. Int J Antimicrob Agents 2003; 21: 510-520.
16. Arenas Y, Monro S, Shi G, et al: Photodynamic inactivation of Staphylococcus aureus and methicillin-resistant S. aureus with Ru(II)-based type I/type II photosensitizers. Photodiagnosis Photodyn Ther 2013; 10: 615-625.
17. Sperandio FF, Huang YY, Hamblin MR: Antimicrobial photodynamic therapy to kill Gram-negative bacteria. Recent Pat Antiinfect Drug Discov 2013; 8: 108-120.
18. Calzavara-Pinton P, Rossi MT, Sala R, et al: Photodynamic antifungal chemotherapy. Photochem Photobiol 2012; 88: 512-522.
19. Paz-Cristobal MP, Royo D, Rezusta A, et al: Photodynamic fungicidal efficacy of hypericin and dimethyl methylene blue against azole-resistant Candida albicans strains. Mycoses 2014; 57: 35-42.
20. Pereira Gonzales F, Maisch T: Photodynamic inactivation for controlling Candida albicans infections. Fungal Biol 2012; 116: 1-10.
21. Wainwright M: Pathogen inactivation in blood products. Curr Med Chem 2002; 9: 127-143.
22. Bonnett R, Krysteva MA, Lalov IG, et al: Water disinfection using photosensitizers immobilized on chitosan. Water Res 2006; 40: 1269-1275.
23. Magaraggia M, Faccenda F, Gandolfi A, et al: Treatment of microbiologically polluted aquaculture waters by a novel photochemical technique of potentially low environmental impact. J Environ Monit 2006; 8: 923-931.
24. Brovko L: Photodynamic treatment. A new efficient alternative for surface sanitation. Adv Food Nutr Res 2010; 61: 119-147.
25. Maisch T, Spannberger F, Regensburger J, et al: Fast and effective: intense pulse light photodynamic inactivation of bacteria. J Ind Microbiol Biotechnol 2012; 39: 1013-1021.
26. Berg K, Folini M, Prasmickaite L, et al: Photochemical internalization: a new tool for drug delivery. Curr Pharm Biotechnol 2007; 8: 362-372.
27. Berg K, Hogset A, Prasmickaite L, et al: Photochemical internalization (PCI): a novel technology for activation of endocytosed therapeutic agents. Med Laser Appl 2006; 21: 239-250.
28. Ogilby PR: Singlet oxygen: there is indeed something new under the sun. Chem Soc Rev 2010; 39: 3181-3209.
29. Mroz P, Bhaumik J, Dogutan DK, et al: Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production. Cancer Lett 2009; 282: 63-76.
30. Fridovich I: Oxygen toxicity: a radical explanation. J Exp Biol 1998; 201: 1203-1209.
31. Fee JA: Is superoxide important in oxygen poisoning? Trends Biochem Sci 1982; 7: 84-86.
32. Winterbourn CC, Kettle AJ: Radical-radical reactions of superoxide: a potential route to toxicity. Biochem Biophys Res Commun 2003; 305: 729-736.
33. d'Alessandro N, Bianchi G, Fang X, et al: Reaction of superoxide with phenoxyl-type radicals. J Chem Soc Perkin Trans II 2000; 1862-1867.
34. Nagy P, Kettle AJ, Winterbourn CC: Superoxide-mediated formation of tyrosine hydroperoxides and methionine sulfoxide in peptides through radical addition and intramolecular oxygen transfer. J Biol Chem 2009; 284: 14723-14733.
35. Misiaszek R, Crean C, Joffe A, et al: Oxidative DNA damage associated with combination of guanine and superoxide radicals and repair mechanisms via radical trapping. J Biol Chem 2004; 279: 32106-32115.
36. Huie RE, Padmaja S: The reaction of NO with superoxide. Free Radic Res Commun 1993; 18: 195-199.
37. Beckman JS, Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite-implications for endothelial injury from nitric-oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
38. Lymar SV, Hurst JK: Rapid reaction between peroxonitrite ion and carbon dioxide: implications for biological activity. J Am Chem Soc 1995; 117: 8867-8868.
39. Medinas DB, Cerchiaro G, Trindade DF, et al: The carbonate radical and related oxidants derived from bicarbonate buffer. IUBMB Life 2007; 59: 255-262.
40. Shafirovich V, Dourandin A, Huang WD, et al: The carbonate radical is a site-selective oxidizing agent of guanine in double-stranded oligonucleotides. J Biol Chem 2001; 276: 24621-24626.
41. Benov L: How superoxide radical damages the cell. Protoplasma 2001; 217: 33-36.
42. Liochev SI, Fridovich I: The role of O2 •-in the production of HO • : in vitro and in vivo. Free Radic Biol Med 1994; 16: 29-33.
43. Liochev SI: The role of iron-sulfur clusters in in vivo hydroxyl radical production. Free Radic Res 1996; 25: 369-384.
44. Imlay JA: The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat Rev Microbiol 2013; 11: 443-454.
45. Fridovich I: Oxygen: how do we stand it? Med Princ Pract 2013; 22: 131-137.
46. Davies MJ: Reactive species formed on proteins exposed to singlet oxygen. Photochem Photobiol Sci 2004; 3: 17-25.
47. DeRosa MC, Crutchley RJ: Photosensitized singlet oxygen and its applications. Coord Chem Rev 2002; 233-234: 351-371.
48. Rodgers MA, Snowden PT: Lifetime of O 2 ( 1 ? g ) in liquid water as determined by timeresolved infrared luminescence measurements. J Am Chem Soc 1982; 104: 5541-5543.
49. Redmond RW, Kochevar IE: Spatially resolved cellular responses to singlet oxygen. Photochem Photobiol 2006; 82: 1178-1186.
50. Ashur I, Goldschmidt R, Pinkas I, et al: Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin. J Phys Chem A 2009; 113: 8027-8037.
51. Pattison DI, Rahmanto AS, Davies MJ: Photooxidation of proteins. Photochem Photobiol Sci 2012; 11: 38-53.
52. Dabrowski JM, Arnaut LG, Pereira MM, et al: New halogenated water-soluble chlorin and bacteriochlorin as photostable PDT sensitizers: synthesis, spectroscopy, photophysics, and in vitro photosensitizing efficacy. Chem Med Chem 2010; 5: 1770-1780.
53. Dabrowski JM, Arnaut LG, Pereira MM, et al: Combined effects of singlet oxygen and hydroxyl radical in photodynamic therapy with photostable bacteriochlorins: evidence from intracellular fluorescence and increased photodynamic efficacy in vitro. Free Radic Bio Med 2012; 52: 1188-1200.
54. Huang YY, Balasubramanian T, Yang E, et al: Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery. Chem Med Chem 2012; 7: 2155-2167.
55. Plowman JE, Deb-Choudhury S, Grosvenor AJ, et al: Protein oxidation: identification and utilisation of molecular markers to differentiate singlet oxygen and hydroxyl radical-mediated oxidative pathways. Photochem Photobiol Sci 2013; 12: 1960-1967.
56. Davies MJ: The oxidative environment and protein damage. Biochim Biophys Acta 2005; 1703: 93-109.
57. Garrison WM: Reaction mechanisms in the radiolysis of peptides, polypeptides, and proteins. Chem Rev 1987; 87: 381-398.
58. Winterbourn CC, Parsons-Mair HN, Gebicki S, et al: Requirements for superoxide-dependent tyrosine hydroperoxide formation in peptides. Biochem J 2004; 381: 241-248.
59. Das AB, Nagy P, Abbott HF, et al: Reactions of superoxide with the myoglobin tyrosyl radical. Free Radic Biol Med 2010; 48: 1540-1547.
60. Alvarez B, Radi R: Peroxynitrite reactivity with amino acids and proteins. Amino Acids 2003; 25: 295-311.
61. Benov L, Craik J, Batinic-Haberle I: Protein damage by photo-activated Zn(II) N-alkylpyridylporphyrins. Amino Acids 2012; 42: 117-128.
62. Afonso SC, Enriquez De Salamanca R, Del C. Batlle AM: The photodynamic and non-photodynamic actions of porphyrins. Brazil J Med Biol Res 1999; 32: 255-266.
63. Al-Mutairi DA, Craik JD, Batinic-Haberle I, et al: Inactivation of metabolic enzymes by photo-treatment with zinc meta-N-methylpyridylporphyrin. Biochim Biophys Acta 2007; 1770: 1520-1527.
64. Girotti AW: Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms. J Photochem Photobiol 2001; 63: 103-113.
65. Doleiden FH, Fahrenholtz SR, Lamola AA, et al: Reactivity of cholesterol and some fatty acids toward singlet oxygen. Photochem Photobiol 1974; 20: 519-521.
66. Girotti AW, Kriska T: Role of lipid hydroperoxides in photo-oxidative stress signaling. Antioxid Redox Signal 2004; 6: 301-310.
67. Yoshida Y, Niki E: Oxidation of methyl linoleate in aqueous dispersions induced by copper and iron. Arch Biochem Biophys 1992; 295: 107-114.
68. Gueraud F, Atalay M, Bresgen N, et al: Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 2010; 44: 1098-1124.
69. Epe B: DNA damage spectra induced by photosensitization. Photochem Photobiol Sci 2012; 11: 98-106.
70. Al-Mutairi DA, Craik JD, Batinic-Haberle I, et al: Photosensitizing action of isomeric zinc N-methylpyridyl porphyrins in human carcinoma cells. Free Radic Res 2006; 40: 477-483.
71. Barrera G, Pizzimenti S, Dianzani MU: Lipid peroxidation: control of cell proliferation, cell differentiation and cell death. Mol Aspects Med 2008; 29: 1-8.
72. Negre-Salvayre A, Auge N, Ayala V, et al: Pathological aspects of lipid peroxidation. Free Radic Res 2010; 44: 1125-1171.
73. Niki E: Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009; 47: 469-484.
74. Uchida K: Lipid peroxidation and redox-sensitive signaling pathways. Curr Atheroscler Rep 2007; 9: 216-221.
75. Cadet J, Ravanat JL, TavernaPorro M, et al: Oxidatively generated complex DNA damage: tandem and clustered lesions. Cancer Lett 2012; 327: 5-15.
76. Cadet J, Douki T, Ravanat JL: One-electron oxidation of DNA and inflammation processes. Nat Chem Biol 2006; 2: 348-349.
77. Cadet J, Douki T, Ravanat JL: Oxidatively generated damage to the guanine moiety of DNA: mechanistic aspects and formation in cells. Acc Chem Res 2008; 41: 1075-1083.
78. Cadet J, Mouret S, Ravanat JL, et al: Photoinduced damage to cellular DNA: direct and photosensitized reactions. Photochem Photobiol 2012; 88: 1048-1065.
79. Cadet J, Douki T, Ravanat JL: Oxidatively generated base damage to cellular DNA. Free Radic Biol Med 2010; 49: 9-21.
80. Pouget JP, Douki T, Richard MJ, et al: DNA damage induced in cells by ? and UVA radiation as measured by HPLC/GC-MS and HPLC-EC and comet assay. Chem Res Toxicol 2000; 13: 541-549.
81. Epe B: Genotoxicity of singlet oxygen. Chem Biol Interact 1991; 80: 239-260.
82. Sies H, Menck CF: Singlet oxygen induced DNA damage. Mutat Res 1992; 275: 367-375.
83. Cooke MS, Loft S, Olinski R, et al: Recommendations for standardized description of and nomenclature concerning oxidatively damaged nucleobases in DNA. Chem Res Toxicol 2010; 23: 705-707.
84. Al-Mutairi DA, Craik JD, Batinic-Haberle I, et al: Induction of oxidative cell damage by photo-treatment with zinc N-methylpyridylporphyrin. Free Radic Res 2007; 41: 89-96.
85. Cadet J, Loft S, Olinski R, et al: Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic Res 2012; 46: 467-481.
86. Cadet J, Wagner JR: DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. Cold Spring Harb Perspect Biol 2013; 5:a012559.
87. Dedon PC: The chemical toxicology of 2-deoxyribose oxidation in DNA. Chem Res Toxicol 2008; 21: 206-219.
88. Castano AP, Demidova TN, Hamblin MR: Mechanisms in photodynamic therapy. Part 2. Cellular signaling, cell metabolism and modes of cell death. Photodiagnosis Photodyn Ther 2005; 2: 1-23.
89. Moan J, Berg K, Kvam E: Effects of photodynamic treatment on DNA and DNA related cell functions; in Photodynamic Therapy of Neoplastic Disease. Boca Raton, CRC Press, 1990.
90. Fuchs J, Weber S, Kaufmann R: Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy. Free Radic Biol Med 2000; 28: 537-548.
91. Ormond AB, Freeman HS: Dye sensitizers for photodynamic therapy. Materials 2013; 6: 817-840.
92. Wolfsen HC: Porfimer sodium photodynamic therapy: the long road to acceptance in America. Photodiagnosis Photodyn Ther 2007; 4: 242-243.
93. Nyman ES, Hynninen PH: Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. J Photochem Photobiol B 2004; 73: 1-28.
94. Pushpan SK, Venkatraman S, Anand VG, et al: Porphyrins in photodynamic therapy: a search for ideal photosensitizers. Curr Med Chem Anticancer Agents 2002; 2: 187-207.
95. Dabrowski JM, Arnaut LG, Pereira MM, et al: Improved biodistribution, pharmacokinetics and photodynamic efficacy using a new photostable sulfonamide bacteriochlorin. Med Chem Commun 2012; 3: 502-505.
96. Yang E, Diers JR, Huang YY, et al: Molecular electronic tuning of photosensitizers to enhance photodynamic therapy: synthetic dicyanobacteriochlorins as a case study. Photochem Photobiol 2013; 89: 605-618.
97. St Denis TG, Hamblin MR: Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy. Bioanalysis 2013; 5: 1099-1114.
98. Master A, Livingston M, Sen Gupta A: Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J Control Release 2013; 168: 88-102.
99. Ricchelli F, Franchi L, Miotto G, et al: Mesosubstituted tetra-cationic porphyrins photosensitize the death of human fibrosarcoma cells via lysosomal targeting. Int J Biochem Cell Biol 2005; 37: 306-319.
100. Agostinis P, Berg K, Cengel KA, et al: Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011; 61: 250-281.
101. Yoon I, Li JZ, Shim YK: Advance in photosensitizers and light delivery for photodynamic therapy. Clin Endosc 2013; 46: 7-23.
102. Castano AP, Demidova TN, Hamblin MR: Mechanisms in photodynamic therapy. Part 1. Photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther 2004; 1: 279-293.
103. Huang YY, Mroz P, Zhiyentayev T, et al: In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers. J Med Chem 2010; 53: 4018-4027.
104. Mroz P, Huang YY, Szokalska A, et al: Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy. FASEB J 2010; 24: 3160-3170.
105. Dabrowski JM, Urbanska K, Arnaut LG, et al: Biodistribution and photodynamic efficacy of a water-soluble, stable, halogenated bacteriochlorin against melanoma. Chem Med Chem 2011; 6: 465-475.
106. Juzeniene A, Nielsen KP, Moan J: Biophysical aspects of photodynamic therapy. J Environ Pathol Toxicol Oncol 2006; 25: 7-28.
107. Aggarwal A, Thompson S, Singh S, et al: Photophysics of glycosylated derivatives of a chlorin, isobacteriochlorin and bacteriochlorin for photodynamic theragnostics: discovery of a two-photon-absorbing photosensitizer. Photochem Photobiol 2014; 90: 419-430.
108. Boyle RW, Dolphin D: Structure and biodistribution relationships of photodynamic sensitizers. Photochem Photobiol 1996; 64: 469-485.
109. Benov L, Batinic-Haberle I, Spasojevic I, et al: Isomeric N-alkylpyridylporphyrins and their Zn(II) complexes: inactive as SOD mimics but powerful photosensitizers. Arch Biochem Biophys 2002; 402: 159-165.
110. Jensen TJ, Vicente MGH, Luguya R, et al: Effect of overall charge and charge distribution on cellular uptake, distribution and phototoxicity of cationic porphyrins in HEp2 cells. J Photochem Photobiol B 2010; 100: 100-111.
111. Ezzeddine R, Al-Banaw A, Tovmasyan A, et al: Effect of molecular characteristics on cellular uptake, subcellular localization, and phototoxicity of Zn(II) N-alkylpyridylporphyrins. J Biol Chem 2013; 288: 36579-36588.
112. Pavani C, Uchoa AF, Oliveira CS, et al: Effect of zinc insertion and hydrophobicity on the membrane interactions and PDT activity of porphyrin photosensitizers. Photochem Photobiol Sci 2009; 8: 233-240.
113. Engelmann FM, Mayer I, Gabrielli DS, et al: Interaction of cationic meso-porphyrins with liposomes, mitochondria and erythrocytes. J Bioenerg Biomembr 2007; 39: 175-185.
114. Tovmasyan A, Reboucas JS, Benov L: Simple biological systems for assessing the activity of superoxide dismutase mimics. Antioxid Redox Signal DOI: 10.1089/ars.2013.5576.
115. Agostinis P, Buytaert E, Breyssens H, et al: Regulatory pathways in photodynamic therapy induced apoptosis. Photochem Photobiol Sci 2004; 3: 721-729.
116. Oleinick NL, Evans HH: The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 1998; 150:S146-S156.
117. Engelmann FM, Rocha SVO, Toma HE, et al: Determination of n-octanol/water partition and membrane binding of cationic porphyrins. Int J Pharm 2007; 329: 12-18.
118. Uzdensky AB: Signal transduction and photodynamic therapy. Curr Signal Transduct Ther 2008; 3: 55-74.
119. Liu T, Wu LY, Berkman CE: Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption. Cancer Lett 2010; 296: 106-112.
120. Stockert JC, Juarranz A, Villanueva A, et al: Photodynamic damage to HeLa cell microtubules induced by thiazine dyes. Cancer Chemother Pharmacol 1996; 39: 167-169.
121. Mroz P, Yaroslavsky A, Kharkwal GB, et al: Cell death pathways in photodynamic therapy of cancer. Cancers (Basel) 2011; 3: 2516-2539.
122. Almeida RD, Manadas BJ, Carvalho AP, et al: Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta 2004; 1704: 59-86.
123. Wu S, Zhou F, Wei Y, et al: Cancer phototherapy via selective photoinactivation of respiratory chain oxidase to trigger a fatal superoxide anion burst. Antioxid Redox Signal 2014; 20: 733-746.
124. Buytaert E, Dewaele M, Agostinis P: Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 2007; 1776: 86-107.
125. Oleinick NL, Morris RL, Belichenko I: The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 2002; 1: 1-21.
126. Benov L, Craik J, Batinic-Haberle I: The potential of Zn(II) N-alkylpyridylporphyrins for anticancer therapy. Curr Med Chem Anticancer Agents 2011; 11: 233-241.
127. MacDonald IJ, Dougherty TJ: Basic principles of photodynamic therapy. J Porphyr Phthalocyanines 2001; 5: 105-129.
128. Francois A, Salvadori A, Bressenot A, et al: How to avoid local side effects of bladder photodynamic therapy: impact of the fluence rate. J Urol 2013; 190: 731-736.
129. Henderson BW, Gollnick SO, Snyder JW, et al: Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res 2004; 64: 2120-2126.
130. Mendoza J, Sebastian A, Allan E, et al: Differential cytotoxic response in keloid fibroblasts exposed to photodynamic therapy is dependent on photosensitiser precursor, fluence and location of fibroblasts within the lesion. Arch Dermatol Res 2012; 304: 549-562.
131. Ibbotson SH, Ferguson J: Ambulatory photodynamic therapy using low irradiance inorganic light-emitting diodes for the treatment of non-melanoma skin cancer: an open study. Photodermatol Photoimmunol Photomed 2012; 28: 235-239.
132. Rogers GS: Continuous low-irradiance photodynamic therapy: a new therapeutic paradigm. J Natl Compr Canc Netw 2012; 10:S-14-S-17.
133. Zeitouni NC, Paquette AD, Housel JP, et al: A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer. Laser Surg Med 2013; 45: 89-94.
134. Ochsner M: Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B 1997; 39: 1-18.
135. Ibbotson SH: Adverse effects of topical photodynamic therapy. Photodermatol Photoimmunol Photomed 2011; 27: 116-130.
136. Attili SK, Dawe R, Ibbotson S: A review of pain experienced during topical photodynamic therapy-our experience in Dundee. Photodiagnosis Photodyn Ther 2011; 8: 53-57.
137. Nyst HJ, Tan IB, Stewart FA, et al: Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer? Photodiagnosis Photodyn Ther 2009; 6: 3-11.
138. Wilson BC, Patterson MS: The physics, biophysics and technology of photodynamic therapy. Phys Med Biol 2008; 53:R61-R109.
139. Silva EFF, Schaberle FA, Monteiro CJP, et al: The challenging combination of intense fluorescence and high singlet oxygen quantum yield in photostable chlorins-a contribution to theranostics. Photochem Photobiol Sci 2013; 12: 1187-1192.
140. Stefflova K, Chen J, Zheng G: Killer beacons for combined cancer imaging and therapy. Curr Med Chem 2007; 14: 2110-2125.
141. Monnereau C, Gallavardin T, Armagnat C, et al: Two-photon absorbing chromophores for photodynamic therapy: molecular engineering and in vivo applications. Proceedings SPIE, San Diego, 2011, article 81030N.
142. Fowley C, Nomikou N, McHale AP, et al: Extending the tissue penetration capability of conventional photosensitisers: a carbon quantum dot-protoporphyrin IX conjugate for use in two-photon excited photodynamic therapy. Chem Commun (Camb) 2013; 49: 8934-8936.
143. Mathews MS, Angell-Petersen E, Sanchez R, et al: The effects of ultra-low fluence rate single and repetitive photodynamic therapy on glioma spheroids. Lasers Surg Med 2009; 41: 578-584.
144. Moghissi K: PDT: the plight. Photodiagnosis Photodyn Ther 2007; 4: 223-223.